Royalty Pharma (RPRX) Shares Outstanding (Entity) (2020 - 2026)

Royalty Pharma (RPRX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 722.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 445.75 Mn
Mar 31, 2026 443.63 Mn
Dec 31, 2025 428.67 Mn
Sep 30, 2025 429.03 Mn
Jun 30, 2025 432.29 Mn
Mar 31, 2025 425.59 Mn
Dec 31, 2024 445.99 Mn
Sep 30, 2024 446.04 Mn
Jun 30, 2024 449.07 Mn
Mar 31, 2024 450.98 Mn
Dec 31, 2023 446.69 Mn
Sep 30, 2023 445.84 Mn
Jun 30, 2023 450.35 Mn
Mar 31, 2023 448.29 Mn
Dec 31, 2022 443.17 Mn
Sep 30, 2022 441.10 Mn
Jun 30, 2022 437.14 Mn
Mar 31, 2022 435.32 Mn
Dec 31, 2021 432.96 Mn
Sep 30, 2021 429.51 Mn